COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: Vitamin supplementation in order (ampoules): 25,000 international units of vitamin A daily, 600,000 international units of vitamin D once during the intervention ti
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age between 20 and 60 years Both males and females COVID-19 clinical or definitive diagnosis Satisfaction with the study patient do not participate in other trial designs BMI: 18.5-30 - Lack of renal and hepatic abnormalities
Exclusion criteria
Exclusion criteria: Patients with specific and rare viral diseases such as HIV etc. Patients have been undergoing chemotherapy for the past month Any other patients that the specialist knows to be unique.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WBC, CRP, IL6,TNF-a, IFN-G ? ESR. Timepoint: Before and after intervention. Method of measurement: Laboratory blood test.;Intensity of pulmonary involvement. Timepoint: Before and after intervention. Method of measurement: CT scan.;Mortality. Timepoint: Before and after intervention. Method of measurement: Observation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index. Timepoint: Before and after intervention. Method of measurement: Measuring weight and height and using the formula.;Duration of hospitalization. Timepoint: Before and after intervention. Method of measurement: Observation.;Saturation percentage of blood oxygen. Timepoint: Before and after intervention. Method of measurement: Oxymeter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSama Bitarafan
Tehran University of Medical Sciences
Outcome results
None listed